These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4151332)

  • 41. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An outbreak of cases of Raynaud's phenomenon of occupational origin.
    AGATE JN
    Br J Ind Med; 1949 Jul; 6(3):144-63. PubMed ID: 18132349
    [No Abstract]   [Full Text] [Related]  

  • 43. Varieties of digital ischemia and their management.
    EDWARDS EA
    N Engl J Med; 1954 Apr; 250(17):709-16. PubMed ID: 13165887
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of nitroglycerin on finger artery blood pressure].
    Hänsgen K; Podhaisky H; Sternitzky R
    Vasa Suppl; 1991; 32():396-401. PubMed ID: 1771543
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
    Whitmore SE; Wigley FM; Wise RA
    J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exertional numbness as a unique feature in intermittent claudication.
    Lennihan R; Mackereth M
    Angiology; 1973 Oct; 24(9):563-9. PubMed ID: 4271298
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the effect of alpha- and of beta-adrenergic blocking agents on the circulation in human limbs.
    Clement DL
    Verh K Acad Geneeskd Belg; 1980; 42(3-4):164-214. PubMed ID: 6114601
    [No Abstract]   [Full Text] [Related]  

  • 49. Raynaud's phenomenon and atypical causalgia; the role of sympathectomy.
    KLEINSASSER LJ
    Ann Surg; 1948 May; 127(4):720-9. PubMed ID: 18917128
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of dazoxiben, a thromboxane synthetase inhibitor on skin-blood flow following cold challenge in patients with Raynaud's phenomenon.
    Tindall H; Tooke JE; Menys VC; Martin MF; Davies JA
    Eur J Clin Invest; 1985 Feb; 15(1):20-3. PubMed ID: 3921380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raynaud's Phenomenon, with Paroxysmal Hæmoglobinuria, Caused by Cold Hæmagglutination.
    Whittle CH; Lyell A; Gatman M
    Proc R Soc Med; 1947 Jul; 40(9):500-2. PubMed ID: 19993603
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.
    Rustin MH; Almond NE; Beacham JA; Brooks RJ; Jones DP; Cooke ED; Dowd PM
    Br J Dermatol; 1987 Dec; 117(6):751-8. PubMed ID: 3322358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial.
    Tucker AT; Pearson RM; Cooke ED; Benjamin N
    Lancet; 1999 Nov; 354(9191):1670-5. PubMed ID: 10568568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
    Khan F; Coffman JD
    Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)].
    Shcherbakov AB; Guseva NG; Mach ES
    Ter Arkh; 1985; 57(5):141-4. PubMed ID: 4023933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
    Freedman RR; Moten M; Migály P; Mayes M
    Arthritis Rheum; 1993 May; 36(5):685-90. PubMed ID: 8387786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.
    Miyazaki S; Miura K; Kasai Y; Abe K; Yoshinaga K
    Br Med J (Clin Res Ed); 1982 Jan; 284(6312):310-11. PubMed ID: 6174171
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.
    Yardumian DA; Isenberg DA; Rustin M; Belcher G; Snaith ML; Dowd PM; Machin SJ
    Br J Rheumatol; 1988 Jun; 27(3):220-6. PubMed ID: 2454140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of intravenously administered isoxsuprine in patients with Raynaud's phenomenon.
    Wesseling H; Wouda AA
    Vasa; 1975; 4(2):168-74. PubMed ID: 1136570
    [No Abstract]   [Full Text] [Related]  

  • 60. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
    Royds RB
    Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.